These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8916120)

  • 1. Analysis of p53 gene mutations in human glioma cell lines.
    Koga H; Zhang S; Washiyama K; Ichikawa T; Onda K; Kumanishi T
    Noshuyo Byori; 1996 Apr; 13(1):1-10. PubMed ID: 8916120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered subcellular localization and low frequency of mutations of ING1 in human brain tumors.
    Vieyra D; Senger DL; Toyama T; Muzik H; Brasher PM; Johnston RN; Riabowol K; Forsyth PA
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5952-61. PubMed ID: 14676120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations of the p53 gene in gliomas from Malay patients.
    Jafri A; Aziz MY; Ros S; Nizam I
    Med J Malaysia; 2003 Jun; 58(2):236-42. PubMed ID: 14569744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
    Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
    Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C.
    Giglia G; Dumaz N; Drougard C; Avril MF; Daya-Grosjean L; Sarasin A
    Cancer Res; 1998 Oct; 58(19):4402-9. PubMed ID: 9766670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
    Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
    Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of p53 autoantibodies in sera from glioma patients.
    Rainov NG; Dobberstein KU; Fittkau M; Bahn H; Holzhausen HJ; Gantchev L; Burkert W
    Clin Cancer Res; 1995 Jul; 1(7):775-81. PubMed ID: 9816045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation analysis of DKK1 and in vivo evidence of predominant p53-independent DKK1 function in gliomas.
    Mueller W; Lass U; Wellmann S; Kunitz F; von Deimling A
    Acta Neuropathol; 2005 Mar; 109(3):314-20. PubMed ID: 15668788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant p53 protein expression and function in a panel of hematopoietic cell lines with different p53 mutations.
    Kamihira S; Terada C; Sasaki D; Yanagihara K; Tsukasaki K; Hasegawa H; Yamada Y
    Eur J Haematol; 2009 Apr; 82(4):301-7. PubMed ID: 19220422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines.
    Liu Y; Bodmer WF
    Proc Natl Acad Sci U S A; 2006 Jan; 103(4):976-81. PubMed ID: 16418264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTEN gene mutations are seen in high-grade but not in low-grade gliomas.
    Rasheed BK; Stenzel TT; McLendon RE; Parsons R; Friedman AH; Friedman HS; Bigner DD; Bigner SH
    Cancer Res; 1997 Oct; 57(19):4187-90. PubMed ID: 9331072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The p53 gene and its role in human brain tumors.
    Bögler O; Huang HJ; Kleihues P; Cavenee WK
    Glia; 1995 Nov; 15(3):308-27. PubMed ID: 8586466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of p33ING1 mRNA and chemosensitivity in brain tumor cells.
    Tallen G; Riabowol K; Wolff JE
    Anticancer Res; 2003; 23(2B):1631-5. PubMed ID: 12820433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missense mutation of the MET gene detected in human glioma.
    Moon YW; Weil RJ; Pack SD; Park WS; Pak E; Pham T; Karkera JD; Kim HK; Vortmeyer AO; Fuller BG; Zhuang Z
    Mod Pathol; 2000 Sep; 13(9):973-7. PubMed ID: 11007037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [p53 gene mutations in brain tumors].
    Koga H; Kumanishi T
    No To Shinkei; 1995 Sep; 47(9):845-55. PubMed ID: 7546933
    [No Abstract]   [Full Text] [Related]  

  • 16. p53 mutation, EGFR gene amplification and loss of heterozygosity on chromosome 10, 17 p in human gliomas.
    Jin W; Xu X; Yang T; Hua Z
    Chin Med J (Engl); 2000 Jul; 113(7):662-6. PubMed ID: 11776043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative assessment of the functional p53 status in glioma cells.
    Kim EL; Yoshizato K; Kluwe L; Meissner H; Warnecke G; Zapf S; Westphal M; Deppert W; Giese A
    Anticancer Res; 2005; 25(1A):213-24. PubMed ID: 15816541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of a novel point mutation in the p53 gene in grade II astrocytomas by PCR-SSCP analysis with additional Klenow treatment.
    Chawengchao B; Petmitr S; Ponglikitmongkol M; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W
    Anticancer Res; 2001; 21(4A):2739-43. PubMed ID: 11724349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of p53 gene in gynecologic tumors].
    Yaginuma Y; Yamashita T; Duenas JC; Katayama H; Ishikawa M
    Rinsho Byori; 1994 Mar; 42(3):235-41. PubMed ID: 8152158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential activation of the Fas/CD95 pathway by Ad-p53 in human gliomas.
    Cerrato JA; Khan T; Koul D; Lang FF; Conrad CA; Yung WK; Liu TJ
    Int J Oncol; 2004 Feb; 24(2):409-17. PubMed ID: 14719118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.